Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Pilotto

Showing results (281-290 of 288) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 288 results.
European Journal of Clinical Pharmacology|August 7, 2021
Correction to: Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trialsFarhad Pazan, Mirko Petrovic, Antonio Cherubini, et al.
Translational Psychiatry|February 2, 2019
Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer's diseaseMaria Carolina Dalmasso, Luis Ignacio Brusco, Natividad Olivar, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis studyJean-Charles Lambert, Kristel Sleegers, Antonio González-Pérez, et al.
Nature Genetics|April 5, 2011
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseasePaul Hollingworth, Denise Harold, Rebecca Sims, et al.
Plos One|June 13, 2014
Gene-wide analysis detects two new susceptibility genes for Alzheimer's diseaseValentina Escott-Price, Céline Bellenguez, Li-San Wang, et al.
Nature Genetics|August 17, 2019
Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processingBrian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Nature Genetics|March 2, 2019
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processingBrian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Nature Genetics|July 18, 2017
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's diseaseRebecca Sims, Sven J van der Lee, Adam C Naj, et al.
Pageof 29

Showing results (281-290 of 288) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 288 results.
European Journal of Clinical Pharmacology|August 7, 2021
Correction to: Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trialsFarhad Pazan, Mirko Petrovic, Antonio Cherubini, et al.
Translational Psychiatry|February 2, 2019
Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer's diseaseMaria Carolina Dalmasso, Luis Ignacio Brusco, Natividad Olivar, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis studyJean-Charles Lambert, Kristel Sleegers, Antonio González-Pérez, et al.
Nature Genetics|April 5, 2011
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseasePaul Hollingworth, Denise Harold, Rebecca Sims, et al.
Plos One|June 13, 2014
Gene-wide analysis detects two new susceptibility genes for Alzheimer's diseaseValentina Escott-Price, Céline Bellenguez, Li-San Wang, et al.
Nature Genetics|August 17, 2019
Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processingBrian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Nature Genetics|March 2, 2019
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processingBrian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Nature Genetics|July 18, 2017
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's diseaseRebecca Sims, Sven J van der Lee, Adam C Naj, et al.
Pageof 29